Sensitivity and specificity estimates for rifampicin
| First author [ref.] | Sensitivity# | Specificity¶ |
| Bang 16 | 1.00 (0.69–1.00) | 1.00 (0.88–1.00) |
| Barnard 17 | 0.99 (0.94–1.00) | 0.99 (0.98–1.00) |
| Hillemann 20 | 0.99 (0.95–1.00) | 1.00 (0.91–1.00) |
| Hillemann 18 | 1.00 (0.78–1.00) | 1.00 (0.87–1.00) |
| Hillemann 19 | 0.99 (0.93–1.00) | 1.00 (0.93–1.00) |
| Hillemann 19 | 0.99 (0.93–1.00) | 1.00 (0.93–1.00) |
| Hillemann 19 | 0.97 (0.83–1.00) | 0.95 (0.83–0.99) |
| Hillemann 19 | 0.97 (0.83–1.00) | 0.95 (0.83–0.99) |
| Makinen 21 | 0.96 (0.82–1.00) | 1.00 (0.86–1.00) |
| Miotto 23 | 0.94 (0.88–0.97) | 0.95 (0.87–0.99) |
| Miotto 23 | 1.00 (0.16–1.00) | 1.00 (0.90–1.00) |
| Miotto 22 | 1.00 (0.29–1.00) | 0.98 (0.91–1.00) |
| Miotto 22 | 1.00 (0.29–1.00) | 0.98 (0.92–1.00) |
| Somoskovi 24 | 1.00 (0.86–1.00) | 0.97 (0.92–0.99) |
Data are presented in % (confidence interval). #: Chi-squared = 12.57; degrees of freedom = 13 (p = 0.4817); inconsistency (I-squared) = 0.0%; ¶: Chi-squared = 18.75; degrees of freedom = 13 (p = 0.1310); inconsistency (I-squared) = 30.7%. See also figure 2⇑.